|
President Clinton, Pfizer, and Mylan Announce New Agreements to Lower Prices of Medicines
|
07 August 2009 |
|
Pfizer in Partnership with Shanghai Institutes for Biological Sciences for Drug Discovery Activities
|
30 July 2009 |
|
Pfizer Reports Second-Quarter 2009 Revenues of $11.0 Billion
|
23 July 2009 |
|
Pfizer Receives Approval From European Commission For Pending Acquisition Of Wyeth
|
18 July 2009 |
|
Pfizer Announces New Phase 1 Data From Two Novel Compounds For Alzheimer's Disease
|
16 July 2009 |
|
Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer
|
03 July 2009 |
|
Pfizer Discontinues Phase 3 Trial of Sutent® in Metastatic Colorectal Cancer
|
01 July 2009 |
|
Sutent Significantly Improved Progression-Free Survival
|
26 June 2009 |
|
Pfizer Expands Its Generics Portfolio
|
22 May 2009 |
|
Pfizer Launches Free Medicines Program For Newly Unemployed Americans
|
15 May 2009 |
|
Pfizer And Wisconsin Alumni Research Foundation (WARF) Sign License Agreement
|
06 May 2009 |
|
Pfizer Reports First-Quarter 2009 Results
|
29 April 2009 |
|
Pfizer And University College London Announce Collaboration To Advance Development Of Stem Cell-Base
|
25 April 2009 |
|
Pfizer and Medicines for Malaria Venture Advancing International Research Efforts
|
23 April 2009 |
|
The First Pharmaceutical Company for Protection of Human Rights in Clinical Research
|
07 April 2009 |
|
Pfizer Development Pipeline Shows Advances In High-Priority Disease Areas
|
03 April 2009 |
|
Significantly More Patients With Cardiovascular Disease Quit Smoking Using Chantix/Champix®
|
01 April 2009 |
|
U.S. Patent & Trademark Office Grants Reissue Patent Relating to Lipitor
|
18 March 2009 |
|
Pfizer Expands Portfolio of Generic Medicines in the U.S. and Europe
|
03 March 2009 |
|
Pfizer Discontinues Development of Two Phase 3 Compounds
|
25 February 2009 |